The store will not work correctly when cookies are disabled.
(E)-2-(1H-Benzoimidazol-2-yl)-3-(3-nitro-phenyl)-acrylonitrile
ID: ALA114935
PubChem CID: 5286534
Max Phase: Preclinical
Molecular Formula: C16H10N4O2
Molecular Weight: 290.28
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: N#C/C(=C\c1cccc([N+](=O)[O-])c1)c1nc2ccccc2[nH]1
Standard InChI: InChI=1S/C16H10N4O2/c17-10-12(8-11-4-3-5-13(9-11)20(21)22)16-18-14-6-1-2-7-15(14)19-16/h1-9H,(H,18,19)/b12-8+
Standard InChI Key: BMVPYKZTAYDWTM-XYOKQWHBSA-N
Molfile:
RDKit 2D
22 24 0 0 0 0 0 0 0 0999 V2000
0.6875 -1.4500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.2042 -0.7875 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
1.5125 -1.4417 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.4000 -3.5875 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
0.2042 -2.1250 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
1.9250 -2.1542 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.5833 -1.0417 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.9250 -0.7292 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.5833 -1.8667 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.9792 -2.8667 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.3417 -0.0125 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
3.9917 -4.3042 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
5.2250 -3.5875 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
2.7500 -2.1542 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.1542 -2.8667 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.3917 -2.1542 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.9750 -1.4375 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.2958 -0.6292 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.2958 -2.2792 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.1542 -1.4417 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.0083 -1.0417 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.0083 -1.8667 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2 1 2 0
3 1 1 0
4 10 1 0
5 1 1 0
6 3 2 0
7 2 1 0
8 3 1 0
9 5 1 0
10 15 1 0
11 8 3 0
12 4 1 0
13 4 2 0
14 6 1 0
15 14 2 0
16 17 1 0
17 20 2 0
18 7 1 0
19 9 1 0
20 14 1 0
21 18 2 0
22 19 2 0
9 7 2 0
21 22 1 0
10 16 2 0
M CHG 2 4 1 12 -1
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 290.28 | Molecular Weight (Monoisotopic): 290.0804 | AlogP: 3.54 | #Rotatable Bonds: 3 |
Polar Surface Area: 95.61 | Molecular Species: NEUTRAL | HBA: 4 | HBD: 1 |
#RO5 Violations: ┄ | HBA (Lipinski): 6 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 10.53 | CX Basic pKa: 3.64 | CX LogP: 3.63 | CX LogD: 3.63 |
Aromatic Rings: 3 | Heavy Atoms: 22 | QED Weighted: 0.45 | Np Likeness Score: -1.81 |
References
1. Saczewski F, Reszka P, Gdaniec M, Grünert R, Bednarski PJ.. (2004) Synthesis, X-ray crystal structures, stabilities, and in vitro cytotoxic activities of new heteroarylacrylonitriles., 47 (13): [PMID:15189040] [10.1021/jm0311036] |